content top

Epimacular Brachytherapy for Wet AMD: 24 Months Results

http://www.evrs.eu/medias/2009/congress/Surgery.flv Authors: TL Jackson, M Farah, JP Duprat, M Avila, GY Fujii, J Rossi, A Santos, R Palank , J Nau, London, UK Advantages: Epimacular brachytherapy (EMB) offers a novel, durable, costeffective treatment for age-related macular degeneration. Methods: Patients with classic, mixed or occult choroidal neovascularisation (CNV) underwent a pars plana vitrectomy followed by 24 Gy beta irradiation...

Read More

Fluid Dynamics Among Different 25-gauge Systems: Principles for Use in Vitreoretinal Surgery

http://www.evrs.eu/medias/2006/congress/Fluid-Dynamics-Among-Different-25-gauge-Systems:-Principles-for-Use-in-Vitreoretinal-Surgery.swf http://www.evrs.eu/medias/2006/congress/Fluid-Dynamics-Among-Different-25-gauge-Systems:-Principles-%20for%20Use-in-Vitreoretinal-Surgery.flv Michel Eid Farah, MD, PhD (São Paulo, Brazil), Octaviano Magalhães Jr., MD (São Paulo, Brazil), Mauricio Maia, MD (São Paulo, Brazil), André Maia, MD (São...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of CNV Secondary to AMD: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary-Intravitreal-Bevacizumab-(Avastin)-for-the-Treatment-of-CNV-Secondary-to-AMD:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), Juan G. Sanchez, MD (Caracas, Venezuela), Lihteh Wu, MD (San Jose, Costa Rica), Jose Dalma-Weiszhausz,...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf http://www.evrs.eu/medias/2006/congress/Primary%20Intravitreal%20Bevacizumab%20(Avastin)%20for%20the%20Treatment%20of%20Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.flv J. Fernando Arevalo, MD, FACS (Caracas,...

Read More

Safety of an Intravitreal Injection of Bevacizumab (Avastin®): Results of a Multicenter Trial

Lihteh Wu, MD (San Jose, Costa Rica), Maria A. Martinez- Castellanos, MD (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Jose A. Roca, MD (Lima, Peru), Francisco J. Rodriguez, MD (Bogota, Colombia), Mauricio Maia, MD (São Paulo, Brazil), Teodoro Evans, MD (San Jose, Costa Rica), Pan...

Read More

Short Term Visual and Anatomic Outcomes Following Intravitreal Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Jose A. Roca, MD (Lima, Peru), Lihteh Wu, MD (San Jose, Costa Rica), Fernando Arevalo, MD (Caracas, Venezuela), Mauricio Maia, MD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Francisco J. Rodriguez, MD (Bogota, Colombia), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Fabio Bom Aggio, MD (São Paulo, Brazil) PURPOSE: To describe the visual and anatomic outcomes of an intravitreal injection of 1.25 mg or 2.5 mg of bevacizumab...

Read More
content top